DCOY Financials

Income Statement
MetricQ1 2026
Revenue
—
Cost of Revenue
0
Gross Profit
—
Operating Expenses
2.3M
R&D
749.8K
SG&A
1.5M
Operating Income
-2283739
EBITDA
-2277815
Net Income
-2224628
EPS (Basic)
$-4.18
EPS (Diluted)
$-4.18
Shares (Diluted)
532.0K
MarketsMoversWatchlist
Decoy Therapeutics (DCOY) — Financials